PMID: 3771110Sep 1, 1986Paper

The use of desmopressin in children with coagulation disorders

International Journal of Pediatric Otorhinolaryngology
O E Brown

Abstract

Hemophilia A, von Willebrand's disease and uremia prolong the bleeding time in affected children. Management of hemorrhage is difficult in these patients, and often requires multiple therapeutic modalities. Desmopressin, a synthetic analog of arginine vasopressin (DDAVP), decreases the bleeding time in patients with these disorders. We describe a case of a child with uremia and spontaneous epistaxis originating from the adenoid. Bleeding was controlled with administration of DDAVP and other measures. DDAVP is effective for the rapid, temporary correction of prolonged bleeding time associated with hemophilia A, von Willebrand's disease or uremia. The use of DDAVP avoids the risks associated with blood component transfusion. DDAVP may be used as a single hemostatic agent in minor surgical procedures, or in combination with other therapeutic modalities in major surgical procedures.

References

Oct 20, 1978·JAMA : the Journal of the American Medical Association·M E Kosman
Aug 1, 1985·Annals of Internal Medicine·D W Richardson, A G Robinson
May 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S J Jubelirer
Dec 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E GottiG Remuzzi
Jan 6, 1983·The New England Journal of Medicine·A C Carvalho
Jan 6, 1983·The New England Journal of Medicine·P M MannucciT S Zimmerman
Jun 1, 1980·Thrombosis Research·D L DewaldR E Smith
Dec 4, 1980·The New England Journal of Medicine·P A JansonD Deykin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.